2022-RA-908-ESGO The importance of pathological ultrastaging for sentinel lymph nodebiopsy in cervical cancer, the final outcome of the Sentix study (CEEGOG-CX01; ENGOT-CX2; NCT02494063)

Kocián, Roman; Koehler, Christhardt; Bajsová, Sylva; Jarkovský, Jiří; Zapardiel, Ignacio; Martino, Giampaolo Di; Lonkhuijzen, Luc van; Sehnal, Borek; Sanchez, O Arencibia; Ibáñez, Blanca Gil; Martinelli, Fabio; Presl, J; Minář, Luboš; Marek, R; Kascak, Peter; Havelka, Pavel; Michał, M; Gorp, Toon Van; Němejcová, Kristýna; Cibula, David

doi:10.1136/ijgc-2022-esgo.69

Search citation statements

Order By: Relevance

Paper Sections

Select...

Cervical Cancer1

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2022

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Roman Kocian et al presented the results of the final outcome of the international prospective SENTIX study, which evaluated the role of sentinel lymph node and the number of levels of pathological examination for the detection of lymph node involvement 10. Six hundred and forty-seven patients with early-stage cervical cancer without suspicious lymph nodes on imaging and bilateral sentinel lymph node detection were analyzed.…”

Section: Cervical Cancermentioning

confidence: 99%

Best original research presented at the 23rd European Congress on Gynaecological Oncology—Best of ESGO 2022

Kacperczyk‐Bartnik

Bizzarri

Ángeles

et al. 2022

Int J Gynecol Cancer

View full text Add to dashboard Cite

Best of ESGO 2022 includes a selection of best original research presented during the 23rd European Congress on Gynaecological Oncology between October 27 and 30, 2022 in Berlin. Out of 1107 submitted abstracts, authors of studies which obtained the highest scores in a blinded review process were invited to present their results during four oral sessions, young investigators session, and oral poster sessions. By means of this publication, we aim to provide readers with an overview of the best quality research presented at the European Society of Gynaecological Oncology (ESGO) 2022.

show abstract

Section: Cervical Cancermentioning

confidence: 99%